IL147640A0 - Transdermal delivery of lasofoxifene - Google Patents

Transdermal delivery of lasofoxifene

Info

Publication number
IL147640A0
IL147640A0 IL14764001A IL14764001A IL147640A0 IL 147640 A0 IL147640 A0 IL 147640A0 IL 14764001 A IL14764001 A IL 14764001A IL 14764001 A IL14764001 A IL 14764001A IL 147640 A0 IL147640 A0 IL 147640A0
Authority
IL
Israel
Prior art keywords
devices
lasofoxifene
carrier vehicle
reservoir
drug
Prior art date
Application number
IL14764001A
Other languages
English (en)
Original Assignee
Watson Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Pharmaceuticals Inc filed Critical Watson Pharmaceuticals Inc
Publication of IL147640A0 publication Critical patent/IL147640A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14764001A 2000-06-01 2001-05-31 Transdermal delivery of lasofoxifene IL147640A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20878900P 2000-06-01 2000-06-01
PCT/US2001/017567 WO2001091724A2 (en) 2000-06-01 2001-05-31 Transdermal delivery of lasofoxifene

Publications (1)

Publication Number Publication Date
IL147640A0 true IL147640A0 (en) 2002-08-14

Family

ID=22776068

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14764001A IL147640A0 (en) 2000-06-01 2001-05-31 Transdermal delivery of lasofoxifene
IL147640A IL147640A (en) 2000-06-01 2002-01-15 Subcutaneous administration of lasofoxifene

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147640A IL147640A (en) 2000-06-01 2002-01-15 Subcutaneous administration of lasofoxifene

Country Status (24)

Country Link
US (1) US20020037311A1 (ru)
EP (1) EP1229909B1 (ru)
JP (1) JP2003534368A (ru)
KR (1) KR100795870B1 (ru)
CN (1) CN1400897A (ru)
AT (1) ATE253910T1 (ru)
AU (2) AU785199B2 (ru)
BR (1) BR0106680A (ru)
CA (1) CA2380769A1 (ru)
CZ (1) CZ2002488A3 (ru)
DE (1) DE60101206T2 (ru)
DK (1) DK1229909T3 (ru)
ES (1) ES2210168T3 (ru)
HK (1) HK1052472A1 (ru)
HU (1) HUP0202592A3 (ru)
IL (2) IL147640A0 (ru)
MX (1) MXPA02001152A (ru)
NZ (1) NZ516582A (ru)
PL (1) PL201222B1 (ru)
PT (1) PT1229909E (ru)
RU (1) RU2328276C2 (ru)
TR (1) TR200400241T4 (ru)
WO (1) WO2001091724A2 (ru)
ZA (1) ZA200200519B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7804912B2 (en) * 2004-09-23 2010-09-28 Motorola, Inc. Method and apparatus for encryption of over-the-air communications in a wireless communication system
US7564908B2 (en) * 2004-09-23 2009-07-21 Motorola, Inc. Method and apparatus for encryption of over-the-air communications in a wireless communication system
FR2905601A1 (fr) * 2006-09-11 2008-03-14 Innoderm Sarl Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques.
WO2009009649A1 (en) * 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
EP2167001A4 (en) * 2007-07-10 2012-10-31 Agile Therapeutics Inc THERMAL DELIVERY DEVICE WITH ULTRASONIC WELDING
WO2013102207A1 (en) * 2011-12-30 2013-07-04 Rosscreening, Inc. Estrogen receptor modulators for reducing body weight
CN103751138A (zh) * 2013-12-31 2014-04-30 北京万全德众医药生物技术有限公司 一种含酒石酸拉索昔芬的口腔崩解片及其制备方法
CN103830196A (zh) * 2014-03-14 2014-06-04 王志刚 一种酒石酸拉索昔芬分散片及其制备方法
CN103830207A (zh) * 2014-03-14 2014-06-04 崔书豪 一种酒石酸拉索昔芬贴膏剂
EP3925599A1 (en) 2015-07-24 2021-12-22 Sorrento Therapeutics, Inc. Methods for better delivery of active agents to tumors
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695170B2 (en) * 1994-12-21 1998-08-06 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
IL120265A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists
US6034102A (en) * 1996-11-15 2000-03-07 Pfizer Inc Atherosclerosis treatment
US6203817B1 (en) * 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
CO5170459A1 (es) * 1999-06-01 2002-06-27 Pfizer Prod Inc Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos

Also Published As

Publication number Publication date
US20020037311A1 (en) 2002-03-28
EP1229909A2 (en) 2002-08-14
ZA200200519B (en) 2003-04-22
NZ516582A (en) 2004-08-27
CA2380769A1 (en) 2001-12-06
DE60101206T2 (de) 2004-09-02
ES2210168T3 (es) 2004-07-01
HUP0202592A3 (en) 2003-07-28
EP1229909B1 (en) 2003-11-12
KR20030025219A (ko) 2003-03-28
HK1052472A1 (zh) 2003-09-19
IL147640A (en) 2007-03-08
HUP0202592A2 (hu) 2002-12-28
WO2001091724A3 (en) 2002-05-30
CN1400897A (zh) 2003-03-05
PL201222B1 (pl) 2009-03-31
DK1229909T3 (da) 2004-03-15
CZ2002488A3 (cs) 2002-06-12
MXPA02001152A (es) 2002-08-20
KR100795870B1 (ko) 2008-01-21
JP2003534368A (ja) 2003-11-18
AU2007200426A1 (en) 2007-02-22
TR200400241T4 (tr) 2004-04-21
PT1229909E (pt) 2004-04-30
BR0106680A (pt) 2002-04-30
WO2001091724A2 (en) 2001-12-06
RU2002105378A (ru) 2003-11-10
RU2328276C2 (ru) 2008-07-10
PL354628A1 (en) 2004-02-09
DE60101206D1 (de) 2003-12-18
AU6523501A (en) 2001-12-11
AU785199B2 (en) 2006-11-02
ATE253910T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
US10709669B2 (en) Microreservoir system based on polysiloxanes and ambiphilic solvents
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
IL147640A0 (en) Transdermal delivery of lasofoxifene
AU3932600A (en) Transdermal drug delivery devices comprising a polyurethane drug reservoir
RU2003128642A (ru) Улучшенная чрескожная терапевтическая система для лечения болезни паркинсона
HU9403555D0 (en) The use of glycerin in moderating transdermal drug delivery
DE602005011653D1 (de) Medizinprodukt mit gewebeabhängiger arzneimittelelution
DE69637768D1 (de) Arzneitmittel zur kontrollierten freisetzung löslicher rezeptoren
MX2010006840A (es) Aparato y métodos para suministrar agentes terapeuticos.
GB9800526D0 (en) Organic compounds
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
HUP0402213A2 (hu) Propilénglikolmonokaprilátot tartalmazó szteroid hormontartalmú transzdermális terápiás rendszer
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
KR100940245B1 (ko) 경피 약물 전달 시스템에 유용한 비반응성 접착제
NZ332746A (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease
WO2001064149A1 (en) Improved transdermal drug patch
IL147247A (en) The mikveh micro-system is based on polysiloxanes and ambiphilic solvents
MXPA02009103A (es) Sistema terapeutico transdermal para la administracion de lerisetron.
MY129063A (en) Transdermal delivery of lasofoxifene
EA200601089A1 (ru) Трансдермальная доставка гормонов без необходимости использования агентов, усиливающих проникновение
AU1174400A (en) Retro-inversion peptides that target git transport receptors and related methods
CN118103036A (zh) 用于透皮施用替扎尼定的透皮治疗系统

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed